Symbols / CMPS Stock $13.05 +3.16% COMPASS Pathways plc

Healthcare • Medical Care Facilities • United Kingdom • NMS
CMPS (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Care Facilities
CEO Mr. Kabir Kumar Nath M.A., M.B.A.
Exch · Country NMS · United Kingdom
Market Cap 1.76B
Enterprise Value 1.29B
Income -192.36M
Sales —
FCF (ttm) 33.07M
Book/sh 2.42
Cash/sh 3.45
Employees 156
Insider 10d —
IPO Sep 18, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -12.35
PEG —
P/S —
P/B 5.39
P/C —
EV/EBITDA -7.43
EV/Sales —
Quick Ratio 3.13
Current Ratio 3.32
Debt/Eq 16.32
LT Debt/Eq —
EPS (ttm) -3.14
EPS next Y -1.06
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-07-30
Earnings (prior) 2026-05-13
ROA -25.64%
ROE -68.48%
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 134.95M
Shs Float 101.49M
Insider Own 7.83%
Instit Own 72.62%
Short Float 5.50%
Short Ratio 1.88
Short Interest 7.33M
52W High 14.76
vs 52W High -11.59%
52W Low 2.47
vs 52W Low 428.13%
Beta 2.51
Impl. Vol. 42.60%
Rel Volume 0.21
Avg Volume 4.13M
Volume 852.08K
Target (mean) $22.20
Tgt Median $18.00
Tgt Low $8.00
Tgt High $70.00
# Analysts 15
Recom Strong_buy
Prev Close $12.65
Price $13.05
Change 3.16%
About

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$22.20
Mean price target
2. Current target
$13.06
Latest analyst target
3. DCF / Fair value
$4.41
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$13.06
Low
$8.00
High
$70.00
Mean
$22.20

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-15 main Maxim Group Buy → Buy $20
2026-05-14 main Morgan Stanley Overweight → Overweight $17
2026-05-14 main RBC Capital Outperform → Outperform $22
2026-05-13 reit BTIG Buy → Buy $14
2026-05-04 init Jefferies — → Buy $18
2026-04-28 reit HC Wainwright & Co. Buy → Buy $70
2026-04-24 init B. Riley Securities — → Buy $17
2026-04-20 reit BTIG Buy → Buy $14
2026-03-26 main Canaccord Genuity Buy → Buy $18
2026-03-25 main Morgan Stanley Overweight → Overweight $16
2026-03-02 main HC Wainwright & Co. Buy → Buy $70
2026-02-18 main Canaccord Genuity Buy → Buy $20
2026-02-18 main Morgan Stanley Overweight → Overweight $18
2026-02-18 main RBC Capital Outperform → Outperform $22
2026-01-23 main RBC Capital Outperform → Outperform $21
2025-11-05 main Morgan Stanley Overweight → Overweight $11
2025-10-13 main BTIG Buy → Buy $14
2025-08-04 main HC Wainwright & Co. Buy → Buy $40
2025-08-01 main Canaccord Genuity Buy → Buy $15
2025-07-15 reit HC Wainwright & Co. Buy → Buy $45
News
RSS: Latest CMPS news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-26 LOXAM TERI Chief Financial Officer — 75,000 $0.00 $0
2026-03-26 NATH KABIR Chief Executive Officer — 175,000 $0.00 $0
2025-03-11 LOXAM TERI Chief Financial Officer — 25,000 $0.00 $0
2024-10-24 GOLDSMITH GEORGE JAY Beneficial Owner of more than 10% of a Class of Security — 776,565 $6.43 $4,993,313
2024-10-24 MALIEVSKAIA EKATERINA Beneficial Owner of more than 10% of a Class of Security — 1,553,130 $6.43 $9,986,626
2024-09-26 ATAI LIFE SCIENCES NV Beneficial Owner of more than 10% of a Class of Security — 2,660,000 $6.05 $16,093,000
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
175.29
+11.57%
157.11
+26.66%
124.04
+29.24%
95.98
Research And Development
118.44
-0.51%
119.04
+36.02%
87.52
+34.53%
65.05
Selling General And Administration
60.60
+2.43%
59.17
+19.77%
49.40
+8.93%
45.35
General And Administrative Expense
60.60
+2.43%
59.17
+19.77%
49.40
+8.93%
45.35
Salaries And Wages
28.22
-13.52%
32.63
+22.86%
26.56
+15.85%
22.93
Other Gand A
32.38
+22.03%
26.54
+16.17%
22.84
+1.86%
22.43
Total Expenses
175.29
+11.57%
157.11
+26.66%
124.04
+29.24%
95.98
Operating Income
-175.29
-11.57%
-157.11
-26.66%
-124.04
-29.24%
-95.98
Total Operating Income As Reported
-179.04
-0.47%
-178.21
-30.15%
-136.92
-24.02%
-110.40
EBITDA
-285.60
-91.92%
-148.82
-29.14%
-115.24
-26.96%
-90.77
Normalized EBITDA
-166.51
-12.67%
-147.78
-24.27%
-118.92
-29.85%
-91.59
Reconciled Depreciation
0.22
-7.30%
0.23
-3.72%
0.24
-26.67%
0.33
EBIT
-285.82
-91.76%
-149.05
-29.07%
-115.48
-26.77%
-91.10
Total Unusual Items
-119.09
-11439.73%
-1.03
-128.00%
3.69
+348.96%
0.82
Total Unusual Items Excluding Goodwill
-119.09
-11439.73%
-1.03
-128.00%
3.69
+348.96%
0.82
Net Income
-287.86
-85.57%
-155.12
-30.94%
-118.46
-29.46%
-91.50
Pretax Income
-290.33
-89.11%
-153.53
-30.46%
-117.68
-29.19%
-91.10
Net Non Operating Interest Income Expense
2.67
-29.66%
3.79
+56.63%
2.42
0.00
Interest Expense Non Operating
4.52
+0.85%
4.48
+103.22%
2.20
0.00
Net Interest Income
2.67
-29.66%
3.79
+56.63%
2.42
0.00
Interest Expense
4.52
+0.85%
4.48
+103.22%
2.20
0.00
Interest Income Non Operating
7.18
-13.13%
8.27
+78.84%
4.62
—
Interest Income
7.18
-13.13%
8.27
+78.84%
4.62
—
Other Income Expense
-117.71
-56220.57%
-0.21
-105.30%
3.94
-19.27%
4.88
Other Non Operating Income Expenses
1.38
+67.68%
0.82
+222.75%
0.26
-93.72%
4.06
Gain On Sale Of Security
-119.09
-11439.73%
-1.03
-128.00%
3.69
+348.96%
0.82
Tax Provision
-2.47
-255.14%
1.59
+104.36%
0.78
+91.18%
0.41
Tax Rate For Calcs
0.00
-96.59%
0.00
+31.58%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-1.01
-293.17%
-0.26
-136.84%
0.70
+348.96%
0.16
Net Income Including Noncontrolling Interests
-287.86
-85.57%
-155.12
-30.94%
-118.46
-29.46%
-91.50
Net Income From Continuing Operation Net Minority Interest
-287.86
-85.57%
-155.12
-30.94%
-118.46
-29.46%
-91.50
Net Income From Continuing And Discontinued Operation
-287.86
-85.57%
-155.12
-30.94%
-118.46
-29.46%
-91.50
Net Income Continuous Operations
-287.86
-85.57%
-155.12
-30.94%
-118.46
-29.46%
-91.50
Normalized Income
-169.79
-10.00%
-154.35
-27.09%
-121.45
-31.77%
-92.17
Net Income Common Stockholders
-287.86
-85.57%
-155.12
-30.94%
-118.46
-29.46%
-91.50
Diluted EPS
-3.08
-33.91%
-2.30
+0.86%
-2.32
-7.41%
-2.16
Basic EPS
-3.08
-33.91%
-2.30
+0.86%
-2.32
-7.41%
-2.16
Basic Average Shares
93.50
+38.56%
67.48
+0.00%
67.48
+59.02%
42.44
Diluted Average Shares
93.50
+38.56%
67.48
+0.00%
67.48
+59.02%
42.44
Diluted NI Availto Com Stockholders
-287.86
-85.57%
-155.12
-30.94%
-118.46
-29.46%
-91.50
Other Taxes
-3.75
+82.24%
-21.10
-63.86%
-12.88
+10.74%
-14.42
Line Item Trend 2023-12-31
Total Assets
275.99
Current Assets
261.30
Cash Cash Equivalents And Short Term Investments
220.20
Cash And Cash Equivalents
220.20
Receivables
28.93
Taxes Receivable
28.93
Prepaid Assets
9.83
Current Deferred Assets
—
Restricted Cash
0.44
Other Current Assets
1.90
Total Non Current Assets
14.69
Net PPE
4.73
Gross PPE
4.73
Accumulated Depreciation
—
Properties
—
Machinery Furniture Equipment
—
Other Properties
4.73
Leases
—
Investments And Advances
0.47
Other Investments
0.47
Non Current Accounts Receivable
—
Non Current Deferred Assets
3.34
Non Current Deferred Taxes Assets
3.34
Non Current Prepaid Assets
5.96
Other Non Current Assets
0.20
Total Liabilities Net Minority Interest
50.24
Current Liabilities
19.60
Payables And Accrued Expenses
9.09
Payables
5.89
Accounts Payable
5.89
Current Accrued Expenses
3.19
Pensionand Other Post Retirement Benefit Plans Current
7.07
Total Tax Payable
0.00
Income Tax Payable
0.00
Current Debt And Capital Lease Obligation
2.41
Current Debt
—
Other Current Borrowings
—
Current Capital Lease Obligation
2.41
Other Current Liabilities
1.04
Total Non Current Liabilities Net Minority Interest
30.64
Long Term Debt And Capital Lease Obligation
30.64
Long Term Debt
28.76
Long Term Capital Lease Obligation
1.88
Stockholders Equity
225.74
Common Stock Equity
225.74
Capital Stock
0.64
Common Stock
0.64
Share Issued
61.94
Ordinary Shares Number
61.94
Treasury Shares Number
0.00
Additional Paid In Capital
621.64
Retained Earnings
-379.61
Gains Losses Not Affecting Retained Earnings
-16.93
Other Equity Adjustments
-16.93
Total Equity Gross Minority Interest
225.74
Total Capitalization
254.50
Working Capital
241.69
Invested Capital
254.50
Total Debt
33.05
Capital Lease Obligations
4.29
Net Tangible Assets
225.74
Tangible Book Value
225.74
Other Equity Interest
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-157.24
-31.93%
-119.19
-22.40%
-97.38
+7.66%
-105.45
Cash Flow From Continuing Operating Activities
-157.24
-31.93%
-119.19
-22.40%
-97.38
+7.66%
-105.45
Net Income From Continuing Operations
-287.86
-85.57%
-155.12
-30.94%
-118.46
-29.46%
-91.50
Depreciation Amortization Depletion
0.22
-7.30%
0.23
-3.72%
0.24
-26.67%
0.33
Depreciation And Amortization
0.22
-7.30%
0.23
-3.72%
0.24
-26.67%
0.33
Other Non Cash Items
9.66
+160.41%
3.71
+39.24%
2.66
+25.26%
2.13
Stock Based Compensation
13.59
-30.37%
19.52
+12.97%
17.28
+31.65%
13.12
Operating Gains Losses
121.41
+15980.66%
0.76
+129.30%
-2.58
-325.85%
1.14
Gain Loss On Investment Securities
122.56
—
—
—
Net Foreign Currency Exchange Gain Loss
-1.15
-252.58%
0.76
+128.85%
-2.62
-329.36%
1.14
Gain Loss On Sale Of PPE
—
0.00
-100.00%
0.04
0.00
Change In Working Capital
-14.25
-221.55%
11.72
+236.58%
3.48
+111.36%
-30.67
Change In Prepaid Assets
-7.95
-336.93%
3.35
-27.32%
4.62
+115.88%
-29.07
Change In Payables And Accrued Expense
-3.87
-138.92%
9.95
+299.96%
2.49
+13.93%
2.18
Change In Accrued Expense
-5.91
-275.90%
3.36
+106.84%
1.62
+616.88%
-0.31
Change In Payable
2.03
-69.14%
6.59
+662.73%
0.86
-65.40%
2.50
Change In Account Payable
2.03
-69.14%
6.59
+662.73%
0.86
-65.40%
2.50
Change In Other Working Capital
0.02
-96.65%
0.69
+141.30%
-1.66
+2.35%
-1.70
Change In Other Current Assets
—
—
—
-0.31
Change In Other Current Liabilities
-2.45
-8.26%
-2.27
-15.62%
-1.96
+5.86%
-2.08
Investing Cash Flow
—
0.00
+100.00%
-0.06
+89.26%
-0.60
Cash Flow From Continuing Investing Activities
—
0.00
+100.00%
-0.06
+89.26%
-0.60
Net PPE Purchase And Sale
—
0.00
+100.00%
-0.06
+89.26%
-0.60
Purchase Of PPE
—
0.00
+100.00%
-0.07
+88.93%
-0.60
Sale Of PPE
—
0.00
-100.00%
0.00
0.00
Capital Expenditure
—
—
-0.07
+88.93%
-0.60
Net Investment Purchase And Sale
—
—
—
0.00
Purchase Of Investment
—
—
—
0.00
Financing Cash Flow
140.71
+120.47%
63.82
-63.28%
173.83
+16614.42%
1.04
Cash Flow From Continuing Financing Activities
140.71
+120.47%
63.82
-63.28%
173.83
+16614.42%
1.04
Net Issuance Payments Of Debt
—
0.00
-100.00%
29.59
0.00
Issuance Of Debt
—
0.00
-100.00%
29.59
0.00
Long Term Debt Issuance
—
0.00
-100.00%
29.59
0.00
Net Long Term Debt Issuance
—
0.00
-100.00%
29.59
0.00
Short Term Debt Issuance
—
—
—
—
Net Short Term Debt Issuance
—
—
—
—
Net Common Stock Issuance
140.36
+435.33%
26.22
-81.91%
144.94
+32839.77%
0.44
Proceeds From Stock Option Exercised
0.35
-99.06%
37.84
+10620.68%
0.35
-41.17%
0.60
Net Other Financing Charges
0.00
+100.42%
-0.24
+77.09%
-1.04
—
Changes In Cash
-16.53
+70.15%
-55.36
-172.47%
76.39
+172.75%
-105.01
Effect Of Exchange Rate Changes
1.04
+438.66%
0.19
-77.62%
0.87
+103.47%
-24.96
Beginning Cash Position
165.47
-25.00%
220.64
+53.88%
143.38
-47.55%
273.35
End Cash Position
149.99
-9.36%
165.47
-25.00%
220.64
+53.88%
143.38
Free Cash Flow
-157.24
-31.93%
-119.19
-22.31%
-97.44
+8.11%
-106.05
Interest Paid Supplemental Data
3.05
-0.65%
3.07
+144.82%
1.25
—
Income Tax Paid Supplemental Data
0.76
-32.65%
1.12
-54.10%
2.44
—
Common Stock Issuance
140.36
+435.33%
26.22
-81.91%
144.94
+32839.77%
0.44
Issuance Of Capital Stock
140.36
+435.33%
26.22
-81.91%
144.94
+32839.77%
0.44
Net Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Issuance
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category